Auro Laboratories Share Price

BSE
269.4
-4.70 (1.84%)
AUROLAB • 13 Jun, 2025 | 03:18 PM
BUY

1Y Annualised Return

28.08%

3Y Annualised Return

46.51%

5Y Annualised Return

39.54%

The current prices are delayed, login or Open Demat Account for live prices.

Auro Laboratories SIP Return Calculator

Over the past

1 year
3 years
5 years

Total Investment of ₹65,00,000

Would have become ₹75,07,824 (+15.50%)

Daily SIP of 25,000 would have become 75,07,824 in 1 year with a gain of 10,07,824 (+15.50%)

Auro Laboratories Stock Performance
Today’s Low - High
263.00
277.00
263.00
277.00
52 Week Low - High
156.40
300.00
156.40
300.00

Open

263.00

Prev. Close

274.10

Volume

1,408.00

Total Traded Value

3.85 L

View details of Market Depth
Auro Laboratories Fundamental

Market Cap (in crs)

170.24

Face Value

10

Turnover (in lacs)

3.85

Key Metrics
Qtr Change %
74.65% Gain from 52W Low
21
Dividend yield 1yr %
0

Auro Laboratories shareholding Pattern

Promoter
52.2%
Public
47.8%
Promoter
52.2%
Public
47.8%
Promoter
52.2%
Public
47.8%
Promoter
52.2%
Public
47.8%
Promoter
52.2%
Public
47.8%
Promoter
52.1%
Public
47.9%

Auro Laboratories Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
269.4
Current Price
Bullish Moving Averages
12
Bearish Moving Averages
4
5Day EMA
276.40
10Day EMA
274.20
12Day EMA
272.90
20Day EMA
268.10
26Day EMA
265.20
50Day EMA
257.20
100Day EMA
247.80
200Day EMA
232.80
5Day SMA
278.90
10Day SMA
276.40
20Day SMA
265.60
30Day SMA
260.10
50Day SMA
255.70
100Day SMA
243.20
150Day SMA
242.30
200Day SMA
234.40
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
879 Rs
1408 Rs
Week Rs
4492 Rs
4985 Rs
Month Rs
4322 Rs
5637 Rs
Resistance & Support
271.05
Pivot
Resistance
First Resistance
279.10
Second Resistance
285.05
Third Resistance
293.10
Support
First Support
265.10
Second support
257.05
Third Support
251.10
Relative Strength Index
56.78
Money Flow Index
62.67
MACD
7.66
MACD Signal
6.99
Average True Range
18.58
Average Directional Index
27.71
Rate of Change (21)
5.24
Rate of Change (125)
15.64

Auro Laboratories Latest News

11 JUN 2025 | Wednesday

Auro Laboratories Ltd - 530233 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

02 JUN 2025 | Monday

Auro Laboratories Ltd - 530233 - Announcement under Regulation 30 (LODR)-Newspaper Publication

31 MAY 2025 | Saturday

Auro Laboratories Ltd - 530233 - Disclosure Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

View More

Auro Laboratories Company background

Founded in: 1989
Managing director: Sharat Deorah
Auro Laboratories Ltd, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API). Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the firstline treatment for type 2 diabetes. The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra. The facility has all the required certifications from Indian authorities and European registration organizationSince inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards. Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA.The Companys primary focus was on AntiDiabetic Drugs, which estimated to be one of the fastest growing therapeutic segments. Currently, it manufacture Metformin Hydrochloride and Glibenclamide and are on the anvil of introducing others within this segment. Additionally, it also undertake Toll/Custom Manufacturing for APIs and Intermediates on contract basis. The manufacturing facility operates are per cGMP norms and has an installed capacity in excess of 500 Tonnes per annum.Auro laboratories has made its presence felt in international markets with a bulk of it production being exported to South East Asia, Middle East and several European Countries. Some of the countries the company exports to are Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain and United Kingdom.The Company received ISO 9001:2000 and WHO cGMPs certification. It also received CERTIFICATE OF SUITABILITY (COS) from the European Directorate of Quality Medicine (EDQM) in September 2006.

As of 13 Jun, 2025, AUROLAB share price is ₹273.2. The stock opened at ₹263 and had closed at ₹274.1 the previous day. During today’s trading session, AUROLAB share price moved between ₹263.00 and ₹277.00, with an average price for the day of ₹270.00. Over the last 52 weeks, the stock has recorded a low of ₹156.40 and a high of ₹300.00. In terms of performance, AUROLAB share price has increased by 18.7% over the past six months and has increased by 28.08% over the last year.

Read More

Auro Laboratories FAQs

The Mutual Fund Shareholding in Auro Laboratories was 0.01% at the end of 13/6/2025.

You can easily buy Auro Laboratories shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Auro Laboratories stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -